Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons

Tong Chi-Chung, Au Kwok-Hung, Ngan, Chow Sin-Ming, Cheung Foon-Yiu, Fu Yiu-Tung, Au, Law

Description

To evaluate prognostic factors that may influence local control (LC) of T1N0 glottic cancer treated by primary radiotherapy (RT) with 6 MV photons. Methods We retrospectively reviewed the medical records of 433 consecutive patients with T1N0 glottic cancer treated between 1983 and 2005 by RT in our institution. All patients were treated with 6 MV photons. One hundred and seventy seven (41%) patients received 52.5 Gy in 23 fractions with 2.5 Gy/fraction, and 256 (59%) patients received 66 Gy in 33 fractions with 2 Gy/fraction. Results The median follow-up time was 10.5 years. The 10-year LC rates were 91% and 87% for T1a and T1b respectively. Multivariate analysis showed LC rate was adversely affected by poorly differentiated histology (Hazard Ratio [HR]: 7.5, p = 0.035); involvement of anterior commissure (HR: 2.34, p = 0.011); fraction size of 2.0 Gy (HR: 2.17, p = 0.035) and tumor biologically effective dose (BED) < 65 Gy 15 (HR: 3.38, p = 0.017). Conclusions The negative impact of anterior commissure involvement could be overcome by delivering a higher tumor BED through using fraction size of > 2.0 Gy. We recommend that fraction size > 2.0 Gy should be utilized, for radiation schedules with five daily fractions each week.

Sujets

• Radiation therapy
• Anterior commissure

Informations

• Publié par: biomed
• Publié le: 01 janvier 2011
• Nombre de lectures: 22
• Langue: English

Extrait

Tonget al.Radiation Oncology2011,6:53 http://www.rojournal.com/content/6/1/53

R E S E A R C HOpen Access Impact and relationship of anterior commissure and timedose factor on the local control of T1N0 glottic cancer treated by 6 MV photons * ChiChung Tong , KwokHung Au, Roger KC Ngan, SinMing Chow, FoonYiu Cheung, YiuTung Fu, Joseph SK Au and Stephen CK Law

Abstract Background:To evaluate prognostic factors that may influence local control (LC) of T1N0 glottic cancer treated by primary radiotherapy (RT) with 6 MV photons. Methods:We retrospectively reviewed the medical records of 433 consecutive patients with T1N0 glottic cancer treated between 1983 and 2005 by RT in our institution. All patients were treated with 6 MV photons. One hundred and seventy seven (41%) patients received 52.5 Gy in 23 fractions with 2.5 Gy/fraction, and 256 (59%) patients received 66 Gy in 33 fractions with 2 Gy/fraction. Results:The median followup time was 10.5 years. The 10year LC rates were 91% and 87% for T1a and T1b respectively. Multivariate analysis showed LC rate was adversely affected by poorly differentiated histology (Hazard Ratio [HR]: 7.5,p= 0.035); involvement of anterior commissure (HR: 2.34,p= 0.011); fraction size of 2.0 Gy (HR: 2.17, p= 0.035) and tumor biologically effective dose (BED) < 65 Gy 15 (HR: 3.38,p= 0.017). Conclusions:The negative impact of anterior commissure involvement could be overcome by delivering a higher tumor BED through using fraction size of > 2.0 Gy. We recommend that fraction size > 2.0 Gy should be utilized, for radiation schedules with five daily fractions each week. Keywords:T1N0 glottic cancer, radiotherapy, 6 MV, anterior commissure, Biologically effective dose

Background Laryngeal cancer is the third most common head and neck (H&N) cancer in Hong Kong. The agestandar dized incidence rate was 2.3 per 100,000 [1] and is com parable to those of other developed countries like USA, the Netherlands and Japan. In Hong Kong, around 95% of early glottic cancer (GC) patients were treated by pri mary radiotherapy (RT) alone [2]. There is extensive published data regarding manage ment of early GC treated by RT with Cobalt60 or 24 megavoltage (MV) photons beam, with local control (LC) rates ranging from approximately 8594% in T1N0 disease [35]. The reported treatment outcome of early GC by primary irradiation with 6 MV photons is limited and conflicting. Some authors reported comparable

* Correspondence: [e-mail] Department of Clinical Oncology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong

results with lower energies [6,7] whereas others raised concern about a poorer outcome [8,9]. We present our institution’s experience in this report.

Methods Patient characteristics In mid 2010, we conducted a retrospective analysis of laryngeal cancer patients referred to our center for radi cal treatment over a 26 year period between January 1983 to December 2005. A total of 1256 consecutive patients were identified. This retrospective study was approved by our Institutional Review Board and Ethics committee. According to the Hong Kong Cancer Regis try, about a quarter of all laryngeal cancer cases diag nosed in Hong Kong over that period were treated in our institution. Out of the 1256 patients, there were 433 previously untreated patients with T1N0 GC.

© 2011 Tong et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.